New combo therapy shows promise for lung cancer brain metastases

This study is for people with advanced non-small cell lung cancer that has spread to the brain. It tests whether adding immunotherapy drugs (nivolumab with or without ipilimumab) to radiation therapy can better control the cancer. The goal is to find the safest and most effective dose and to see if it helps stop the brain tumors from growing. Participants will receive either stereotactic radiosurgery or whole brain radiation along with the immunotherapy.